Lactic acid bacteria-containing chocolate as a practical probiotic product with increased acid tolerance

Biocatalysis and Agricultural Biotechnology

Volumn 4, Issue 4, 2015, Pages 773-777

  Yonejima, Yasunori ^a   Hisa, Keiko ^a   Kawaguchi, Marina ^a   Ashitani, Hiroaki ^b   Koyama, Toshiyuki ^b   Usamikrank, Yoko ^b   Kishida, Nayumi ^c   Kishino, Shigenobu ^c   Ogawa, Jun ^c  

^a Nitto Pharmaceutical Industries Ltd   (Japan)

^b Lotte Co Ltd   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Chocolate; Lactobacillus brevis NTM003; Lactobacillus brevis subsp. coagulans; Tolerance test of simulated digestive juice

Indexed keywords

EID: 84945586704     PISSN: 18788181     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcab.2015.09.001     Document Type: Article

References (10)

1. Azuma Y., Ito K., Sato M. Simulated digestive juice tolerance and inhibitory effect on harmful intestinal bacteria of Lactobacillus gasseri NY0509 and Lactobacillus casei NY1301. Nippon Shokuhin Kagaku Kogaku Kaishi 2001, 48(9):656-663.
2. Kimura I., Ozawa K., Inoue D., Imamura T., Kimura K., Maeda T., Terasawa K., Kashihara D., Hirano K., Tani T., Takahashi T., Miyauchi S., Shioi G., Inoue H., Tsujimoto G. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat. Commun. 2013, 4. 10.1038/ncomms2852.
3. Kishi A., Uno K., Matsubara Y., Okuda C., Kishida T. Effect of the oral administration of Lactobacillus brevis subsp. coagulans on ineterferon-alpha producing capacity in humans. J. Am. Coll. Nutr. 1996, 15(4):408-412.
4. Kishino S., Takeuchi M., Park S.B., Hirata A., Kitamura N., Kunisawa J., Kiyono H., Iwamoto R., Isobe Y., Arita M., Arai H., Ueda K., Shima J., Takahashi S., Yokozeki K., Shimizu S., Ogawa J. Polyunsaturated fatty acid saturation by gut lactic acid bacteria affecting host lipid composition. Proc. Natl. Acad. Sci. USA 2013, 110:17808-17813.
5. Kishida T., 1997. Method of Increasing interferon production in humans. U.S. Pat. No. 5662900.
6. Murakami K., Habukawa C., Nobuta Y., Moriguchi N., Takemura T. The effect of Lactobacillus brevis KB290 against irritable bowel syndrome: a placebo-controlled double-blind crossover trial. Biopsychosoc. Med. 2012, 6(16). 10.1186/1751-0759-6-16.
7. Sakurama H., Kishino S., Uchibori Y., Yonejima Y., Ashida H., Kita K., Takahashi S., Ogawa J. β-Glucuronidase from Lactobacillus brevis useful for baicalin hydrolysis belongs to glycoside hydrolase family 30. Appl. Microbiol. Biotechnol. 2014, 98(9):4021-4032.
8. Sanders M.E. Impact of probiotics on colonizing microbiota of the gut. J. Clin. Gastroenterol. 2011, 45:S115-S119.
9. Tsuboi, Y., Kaneko, N., Sato, A., Lactic acid bacterium having effect of lowering blood uric acid level, J. Pat. No. 5149305.
10. Waki N., Matsumoto M., Fukui Y., Suganuma H. Effects of probiotic Lactobacillus brevis KB290 on incidence of influenza infection among schoolchildren: an open-label pilot study. Lett. Appl. Microbiol. 2014, 59:565-571.